Cargando…

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer

BACKGROUND: The importance of immuno-histological detection of neuroendocrine differentiation in prostatic adenocarcinoma with respect to disease at presentation and Gleason grade is gaining acceptance. There is limited literature on the relative significance of three commonly used markers of NE dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ather, M Hammad, Abbas, Farhat, Faruqui, Nuzhat, Israr, Mohammad, Pervez, Shahid
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628675/ https://www.ncbi.nlm.nih.gov/pubmed/19115997 http://dx.doi.org/10.1186/1471-2490-8-21

Ejemplares similares

Expression of pS2 in prostate cancer correlates with grade and Chromogranin A expression but not with stage
por: Ather, M Hammad, et al.
Publicado: (2004)

Is an excretory urogram mandatory in patients with small to medium-sized renal and ureteric stones treated by extra corporeal shock wave lithotripsy?
por: Ather, M Hammad, et al.
Publicado: (2004)

The genetics of neuroendocrine prostate cancers: a review of current and emerging candidates
por: Ather, M Hammad, et al.
Publicado: (2012)

Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
por: Bilgrami, Shumaila M, et al.
Publicado: (2014)

“Looks Can Be Deceiving”: Adrenal Teratoma Causing Diagnostic Difficulty
por: Nadeem, Mehwash, et al.
Publicado: (2015)

Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers
por: Alexiev, Borislav A, et al.
Publicado: (2007)

Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation
por: Juhlin, Carl Christofer
Publicado: (2021)

Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin
por: Yaqinuddin, Ahmed, et al.
Publicado: (2013)

Non-Invasive Predictors of Response to Tamsulosin for Benign Prostatic Obstruction
por: Shoaib, Mohammad, et al.
Publicado: (2021)

Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
por: Zhang, Qingfu, et al.
Publicado: (2021)

Dedifferentiated Endometrioid Carcinomas with Neuroendocrine Differentiation: A Clinicopathological and Immunohistochemical Study of Three Cases
por: Zhou, Feng, et al.
Publicado: (2020)

A study to correlate histopathology, biochemical marker and immunohistochemical expression of sex-steroid receptors in prostatic growth
por: Naskar, Sukla, et al.
Publicado: (2014)

Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma
por: Dabir, Parag Deepak, et al.
Publicado: (2012)

Urdu translation and validation of the Urogenital Distress Inventory (UDI-6) in women with urinary incontinence
por: Faruqui, Nuzhat, et al.
Publicado: (2019)

Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia
por: Gangkak, Goto, et al.
Publicado: (2017)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

Sympathetic signaling facilitates progression of neuroendocrine prostate cancer
por: Dwivedi, Shubham, et al.
Publicado: (2021)

Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression
por: Xie, Yuchen, et al.
Publicado: (2022)

Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study
por: Beyer, Anna-Sophia Liselott, et al.
Publicado: (2022)

Frequency of Transducer-like Enhancer of Split 1 Immunohistochemical Expression in Synovial Sarcoma: An Institution-based Cross-sectional Study
por: Qureshi, Madiha B, et al.
Publicado: (2019)

The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
por: Sheikh-Ahmad, Mohammad, et al.
Publicado: (2023)

Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases
por: Egashira, Akinori, et al.
Publicado: (2017)

Neuroendocrine Carcinomas of the Canine Mammary Gland: Histopathological and Immunohistochemical Characteristics
por: Nakagaki, Karen Yumi Ribeiro, et al.
Publicado: (2021)

Frequency of Translocation t(11;22)(q24;q12) Using Fluorescence In Situ Hybridization (FISH) in Histologically and Immunohistochemically Diagnosed Cases of Ewing’s Sarcoma
por: Bashir, Muhammad Rizwan, et al.
Publicado: (2020)

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer
por: Xiang, Qian, et al.
Publicado: (2020)

Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2–Sst5)
por: Inzani, Frediano, et al.
Publicado: (2020)

Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer
por: Kufe, Donald
Publicado: (2023)

Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation
por: Ito, Takaaki, et al.
Publicado: (2022)

Immunohistochemical Markers in Endometrial Cancer
por: Mais, Valerio, et al.
Publicado: (2021)

Angiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers
por: Florence, Michelle Etienne Baptistella, et al.
Publicado: (2011)

Epithelial-Mesenchymal Transition Proteins in Neuroendocrine Neoplasms: Differential Immunohistochemical Expression in Different Sites and Correlation with Clinico-Pathological Features
por: Guadagno, Elia, et al.
Publicado: (2020)

The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors—An Overview of the Latest Classifications
por: Gheorghișan-Gălățeanu, Ancuța-Augustina, et al.
Publicado: (2023)

Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
por: Derks, Jules L, et al.
Publicado: (2019)

ASO Author Reflections: Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma
por: Iijima, Misaki, et al.
Publicado: (2019)

Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification
por: Brunner, Stefan M, et al.
Publicado: (2015)

Neuroendocrine Differentiation In Prostate Adenocarcinoma Biopsies And Its Correlation To Histological Grading
por: Marcu, Mădălina, et al.
Publicado: (2010)

Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response
por: Lee, Ho-chang, et al.
Publicado: (2013)

New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer
por: Ather, M Hammad, et al.
Publicado: (2015)

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
por: Wang, Zheng, et al.
Publicado: (2020)

Frequency of Electrolyte Derangement after Transurethral Resection of Prostate: Need for Postoperative Electrolyte Monitoring
por: Aziz, Wajahat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_56nktf26t2fvqkcf7c714br8ln